1. Home
  2. BNR vs SCM Comparison

BNR vs SCM Comparison

Compare BNR & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.02

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$8.97

Market Cap

267.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
SCM
Founded
2014
2012
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
267.2M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
BNR
SCM
Price
$9.02
$8.97
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
10.1K
147.3K
Earning Date
06-05-2026
05-11-2026
Dividend Yield
N/A
14.22%
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
N/A
Revenue This Year
$111.65
$0.33
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$153.17
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$8.43
52 Week High
$41.72
$15.39

Technical Indicators

Market Signals
Indicator
BNR
SCM
Relative Strength Index (RSI) 20.79 38.40
Support Level $7.99 $8.93
Resistance Level $9.70 $9.85
Average True Range (ATR) 1.17 0.26
MACD -0.72 -0.02
Stochastic Oscillator 2.40 11.23

Price Performance

Historical Comparison
BNR
SCM

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.

Share on Social Networks: